Krebs Biochemicals & Industries Ltd Share Price History : Returns Comparison, Growth Analysis

Home

Insights

History

Krebs Biochemicals & Industries Ltd Share Price History

Last Updated on: Dec 13, 2024

Krebs Biochemicals & Industries Ltd

BSE

13 Dec, 2024

107.8-0.4 (-0.4%)

Prev Close

108.25

Open Price

108.25

Bid Price (QTY)

Offer Price (QTY)

Volume

337

Today's High / Low

108.3 / 106.0

52 WK High / Low

129.0 / 60.0

NSE

13 Dec, 2024

106.59-1.4 (-1.3%)

Prev Close

108

Open Price

111

Bid Price (QTY)

Offer Price (QTY)

Volume

5903

Today's High / Low

111.0 / 105.0

52 WK High / Low

129.1 / 60.3

Open Demat Account

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Market Price of Krebs Biochemicals & Industries Ltd

To make informed investment decisions, regularly checking Krebs Biochemicals & Industries Ltd share price can be a beneficial practice. *All values are in Rupees.

Last Ten Days Market Price

Date	Price (₹)	Day Open (₹)	Day High (₹)	Day Low (₹)

12 Dec 2024	108.25	106.8	112.9	106.8
11 Dec 2024	110.9	108.5	114.5	108
10 Dec 2024	108	109.85	110	107
09 Dec 2024	110.35	115	115.5	108.65
06 Dec 2024	114.15	107	114.15	106.3
05 Dec 2024	103.8	105.5	105.75	102.8
04 Dec 2024	105.4	105	107.1	103.15
03 Dec 2024	108	111	111	106.2
02 Dec 2024	109.45	107	112.4	106.65
29 Nov 2024	104.38	112	112	103

Date	Price (₹)
12 Dec 2024	108.25
11 Dec 2024	110.9
10 Dec 2024	108
09 Dec 2024	110.35
06 Dec 2024	114.15
05 Dec 2024	103.8
04 Dec 2024	105.4
03 Dec 2024	108
02 Dec 2024	109.45
29 Nov 2024	104.38

Returns Comparison

10Y

Returns Comparison Table

Entity	1W	1M	3M	6M	1Y	3Y	5Y	10Y

Cipla Ltd	-3.5	-5.1	-12.7	-6.1	20.7	62.3	214.0	126.0
Torrent Pharmaceuticals Ltd	-1.0	5.6	-3.8	15.0	62.5	117.0	258.2	523.1
Krebs Biochemicals & Industries Ltd	4.3	25.3	21.5	46.8	31.4	-35.7	27.4	189.7
Sun Pharmaceuticals Industries Ltd	-0.3	0.3	-3.2	19.8	48.2	136.5	316.0	114.3
Divis Laboratories Ltd	-2.4	2.4	8.5	33.7	63.1	31.3	225.0	598.3
Mankind Pharma Ltd	1.2	0.8	9.0	19.2	43.3	0.0	0.0	0.0

Entity	1W
Cipla Ltd	-3.5
Torrent Pharmaceuticals Ltd	-1.0
Krebs Biochemicals & Industries Ltd	4.3
Sun Pharmaceuticals Industries Ltd	-0.3
Divis Laboratories Ltd	-2.4
Mankind Pharma Ltd	1.2

Last updated time: 13 Dec 15:30 PM

Growth Parameters

Parameter	2017	2018	2019	2020	2021	2022	2023	2024

Sales	4	34	48	33	54	60	52	50
Sales YoY Gr.	-	856.9%	41.4%	-30.0%	60.7%	11.2%	-12.7%	-3.3%
Adj EPS	0	0	0	-16.04	-14.45	-20.65	-11.45	-9.15
YoY Gr.	-	0.0%	0.0%	-1604.0%	-9.9%	42.9%	-44.5%	-20.1%
Adj Net Profit	-16	-18	-20	-29	-28	-45	-25	-20
BVPS	1.07	-12.94	-8.59	-13.89	-23.91	-34.83	-46.13	-55.29

Parameter	2017
Sales	4
Sales YoY Gr.	-
Adj EPS	0
YoY Gr.	-
Adj Net Profit	-16
BVPS	1.07

Key Financial Parameters

Parameter	2014	2015	2017	2018	2019	2020	2021	2022	2023	2024

Return on Capital Emp. %	0	0	0	0	0	0	0	0	0	0
Op. Profit Mgn %	0	0	-235.98	-25.19	-19.51	-54.44	-31.56	-55.01	-29.08	-16.4
Net Profit Mgn %	0	0	-454.67	-52.75	-41.9	-86.41	-52.81	-74.59	-47.36	-39.13
Debt to Equity %	16.1	7.04	5.39	0	0	0	0	2.23	0.78	2.83

Parameter	2014
Return on Capital Emp. %	0
Op. Profit Mgn %	0
Net Profit Mgn %	0
Debt to Equity %	16.1

Latest Shareholding

No data available

Promoters Holdings Over Time

No data available

About Krebs Biochemicals & Industries Ltd

Krebs Biochemicals & Industries Ltd (Formerly Krebs Biochemicals Ltd), promoted by R T Ravi in 1991 is engaged in the manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process, one among very few in the world to do the same. Krebs develops commercially viable biotech processes for application in medicine, agriculture and industry.
Undertaking contract manufacturing for large pharmaceutical and multinational companies and developing products for sale in global markets, the Company possesses expertise and infrastructure in chemical synthesis, fermentation and enzymatic technologies. KBIL which commenced commercial operations in the year 1994 with an installed capacity of 60 TPA has now grown to 150 TPA. KBL went to public with an IPO in 1994. During 2001-02, the company launched Vitamin C(I P Grade) through Fermentation Process.

Krebs Biochemicals & Industries Ltd pe ratio

Krebs Biochemicals & Industries Ltd market cap

Krebs Biochemicals & Industries Ltd financials

Sun Pharmaceuticals Industries Ltd share price history

Divis Laboratories Ltd share price history

Cipla Ltd share price history

Torrent Pharmaceuticals Ltd share price history

Mankind Pharma Ltd share price history

Dr Reddys Laboratories Ltd share price history

Zydus Lifesciences Ltd share price history

Lupin Ltd share price history

Aurobindo Pharma Ltd share price history

Alkem Laboratories Ltd share price history

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.